Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Net Cash Flow: 2022-2023

Historic Net Cash Flow for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to $86.0 million.

  • Lexeo Therapeutics' Net Cash Flow rose 611.58% to $86.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $44.2 million, marking a year-over-year change of. This contributed to the annual value of -$86.5 million for FY2024, which is 295.90% down from last year.
  • As of Q4 2023, Lexeo Therapeutics' Net Cash Flow stood at $86.0 million, which was up 952.50% from -$10.1 million recorded in Q3 2023.
  • Lexeo Therapeutics' 5-year Net Cash Flow high stood at $86.0 million for Q4 2023, and its period low was -$18.5 million during Q1 2023.
  • For the 2-year period, Lexeo Therapeutics' Net Cash Flow averaged around $5.5 million, with its median value being -$13.3 million (2023).
  • Data for Lexeo Therapeutics' Net Cash Flow shows a peak YoY spiked of 611.58% (in 2023) over the last 5 years.
  • Over the past 2 years, Lexeo Therapeutics' Net Cash Flow (Quarterly) stood at -$16.8 million in 2022, then skyrocketed by 611.58% to $86.0 million in 2023.
  • Its last three reported values are $86.0 million in Q4 2023, -$10.1 million for Q3 2023, and -$13.3 million during Q2 2023.